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Abstract Actinomyces europaeus was first described in
1997 as a new species causing predominantly skin and soft-
tissue infections. Mastitis due to A. europaeus is an unusual
condition. This article reports a case of primary breast
abscess caused by A. europaeus in a postmenopausal woman.
Keywords Actinomyces europaeus  Actinomycosis 
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Introduction
Actinomyces spp. normally colonizes mucous membranes
particularly of the oral cavity, the colon, and the vagina.
Disruption of the mucosa may lead to indolent infections
characterized by a chronic course, progression across tissue
boundaries, and formation of sinus tracts. Until recently,
identification of Actinomyces spp. was based on phenotypic
tests. With increasing use of genotypic analysis taxonomy
has advanced and new species have been described in the
past 15 years. The disease-causing potential of many of
these newly described species and the associated range of
clinical manifestations is, however, incompletely
understood.
A. europaeus is a Gram-positive, nonmotile, non-spore-
forming facultative anaerobic rod first described as new
species in 1997 on the basis of 16S rRNA gene sequencing
[1]. It was found to cause infections of the urinary tract and
of skin and soft-tissue, notably abscesses, pilonidal sinus
infection, and decubital ulcers [2]. In this article we report
a case of primary breast abscess caused by A. europaeus in
a postmenopausal woman.
Case report
A 67-year-old immunocompetent woman was admitted to
the hospital because of a painful swelling and hyperemia of
the left breast which had appeared 3 days earlier. There
was no history of fever, nipple discharge, tooth problems,
or lung or breast disease. She was not diabetic and was a
non-smoker. Two months earlier, she had undergone
uncomplicated open heart surgery to receive a prosthetic
aortic valve for severe aortic stenosis.
On physical examination, the patient was afebrile and
there were no signs of systemic disease. Her body mass
index was 28.9 kg/m2. There was a tender, fluctuating mass
of 12 cm in the left breast. The overlying skin was infil-
trated and erythematous. The margin of the inflamed skin
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reached within 2 cm of the sternotomy scar which was
without signs of inflammation. Sternal compression was
not painful.
Results of laboratory tests showed a hemoglobin level of
114 g/L, a WBC of 12.3 G/L without a left shift, a
thrombocyte count of 117 G/L, and a level of C-reactive
protein of 35 mg/L. A chest X-ray was normal and a
computed tomography scan of the thorax showed no signs
of infection of the sternum or of intrathoracic tissues.
Blood cultures were negative. The clinically diagnosed
breast abscess was incised and drained under general
anesthesia. Pus and tissue samples were sent for microbi-
ological examination and for histopathology. Postopera-
tively there was a tender mass of 12 9 6 cm in the inferior
half of the breast. The wound was left open and a drainage
tube was inserted. Two days later, the patient was free from
pain and was discharged on oral amoxicillin-clavulanic
acid 1 g tid.
Histopathology showed adipose-tissue necrosis, no sul-
fur granules, and no evidence of malignancy. Gram stains
of pus revealed many Gram-negative bacilli and Gram-
positive rods. Again, no sulfur granules were seen. Cultures
grew Actinomyces spp. and a mixed anaerobic flora com-
posed of Gram-negative rods and Gram-positive cocci that
was not further characterized. A. europaeus was identified
by full-length sequencing of the 16S rRNA gene by using
MicroSeq Full Gene 16S rDNA PCR and sequencing kits
(Applied Biosystems). BLAST analysis showed 99.7%
identity with the 16S rRNA gene sequence of A. europaeus
strain CCUG 32789A (GenBank accession no.
NR_026363). The isolate was tested for susceptibility
using the E test (AB Biodisk, Solna, Sweden) with the
following results: penicillin G MIC: 0.008 lg/mL, amox-
icillin MIC: 0.023 lg/mL, ceftriaxone MIC: 0.047 lg/mL,
piperacillin-tazobactam MIC: 0.047 lg/mL, clindamycin
MIC: 0.016 lg/mL, and tetracycline MIC: 0.380 lg/mL.
According to the Clinical and Laboratory Standards Insti-
tute criteria the isolate was susceptible to all tested anti-
microbial agents [3].
After three weeks, under the assumption that the mixed
anaerobic flora had been eliminated, treatment was
changed to amoxicillin 2 g tid for 4 weeks followed by
amoxicillin 1 g tid for the remainder of the treatment
period. The breast remained non-tender and painless. The
tissue mass, infiltrated skin, and wound secretions
improved only very slowly. After three months, three
draining sinuses secreting minimal amounts of pus
developed on the inferior aspect of the breast (Fig. 1).
The opening left by the abscess drainage healed by
granulation after 10 months. The draining sinuses that
were de´brided regularly resolved after 15 months. At that
time the antibiotic treatment was discontinued. At follow-
up, 6 months later, there were no signs of recurrent
infection; the breast was free of masses and its shape was
only minimally altered by scar formation.
Discussion
The main clinical manifestations of actinomycosis are
slowly progressing, granulomatous and sinus-forming
infections in the cervicofacial, thoracic, abdominal, and, in
women, pelvic areas. Adjacent organs may be infiltrated
but hematogenous dissemination has not been observed.
The disease is four times more common in men; usually
patients are in good health, free from underlying diseases
[4].
Breast infections are relatively common, particularly in
lactating women. They are often caused by bacteria of
normal skin or oral flora, especially Staphylococcus aureus.
Breast infections with Actinomyces spp. are rare and have
mainly been described in premenopausal women [5]. They
are classified as primary or secondary, depending on how
the microorganisms reach the site of infection. Secondary
actinomycosis of the breast results from pulmonary infec-
tion penetrating through the thoracic wall [5, 6]. The more
common primary form occurs when skin flora reach
mammary tissue directly, possibly through cracks in the
skin on or around the nipple. Risk factors for development
of primary breast abscess include smoking, diabetes, and
obesity [7]. Primary actinomycosis of the breast has most
commonly been ascribed to A. israelii [4]. More recently,
breast infections due to A. viscosus, A. turicensis, and
A. radingae have been described [8, 9]. Seven of the ten
Fig. 1 Photograph of the patient’s left breast 6 months after abscess
drainage and start of antibiotic therapy. The incision wound on the
medial aspect is healing, the mass in the inferior medial quadrant and
erythematous skin have improved. On the inferior aspect draining
sinuses that formed after 3 months of antibiotic therapy are covered
by necrotic membranes that are regularly de´brided. Eventual healing
was observed after 15 months of treatment
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clinical strains in the first description of A. europaeus were
isolated from human abscesses, one of which was a breast
abscess in a 54-year-old woman [1]. Interestingly, sulfur
granules have not been described in abscesses due to A.
europaeus and were not found in this case [1, 2, 9].
Absence of sulfur granules has also been observed in
infections caused by A. neuii, another Actinomyces species
not commonly associated with classical actinomycosis
[10].
The patient described here did not have pulmonary
disease or evidence of osteomyelitis of the sternum or the
ribs. It is plausible that actinomycetes reached mammary
tissues through skin lacerations caused by post-sternotomy
dressings.
Interestingly, the association of A. europaeus with other
bacteria is more common than its isolation in pure culture.
Clarridge et al. [11] found them associated with coagulase-
negative staphylococci and corynebacteria and suggested
that the normal niche of A. europaeus was the skin of the
upper body. Sabbe et al. [2] found A. europaeus accom-
panied by a mixed anaerobic flora, as in the case described
here. Attar et al. [8] also described two cases of actino-
mycosis of the breast (caused by strains other than A. eu-
ropaeus) in association with anaerobic bacteria.
The most common clinical presentation of actinomy-
cosis of the breast is recurrent retropapillary abscesses.
Fistulas and purulent or bloody discharge from sinuses may
occur. In the most advanced cases, fibrosis with local cic-
atrisation and distortion of the breast were reported [4]. In
one series, two-thirds of the cases presented as persistent or
recurrent breast abscesses and the other third presented
with a breast lump suggestive of carcinoma [12]. Further
differential diagnoses include tuberculosis, syphilis, rib
osteomyelitis, and inflammatory carcinoma [5].
Recommended treatment for actinomycosis is intrave-
nous penicillin at a daily dose of 18–24 million U for
2–6 weeks, followed by oral penicillin or amoxicillin for a
period of 6–12 months. Shorter treatment regimens may
also be successful [13]. In the case presented here, how-
ever, treatment was given for 15 months, until full closure
of all skin lesions. All reported cases of Actinomyces spp.
of the breast have been successfully treated with a com-
bination of surgical drainage and short-course antibiotic
therapy [8, 9]. Surgical curettage is an important adjunctive
treatment because of limited penetration of the antibiotics
into the chronically indurated tissue of actinomycotic
lesions and the dense aggregates of Actinomyces spp.
known as sulfur granules.
A. europaeus seems to be susceptible in vitro to a wide
range of b-lactam antibiotics which should be regarded as
agents of first choice. Some A. europaeus have reduced
susceptibility to tetracycline, ciprofloxacin, clindamycin,
linezolid, and piperacillin/tazobactam [14]. The isolate
reported here was fully susceptible to all b-lactam agents
tested, and to clindamycin and tetracycline. In mixed
infections with anaerobes amoxicillin–clavulanic acid may
be preferred for initial treatment because of the notable b-
lactamase activity of certain anaerobes.
Physicians and microbiologists should be aware that the
clinical range of disease manifestations due to Actinomyces
spp. may be widening and that new species may be causing
particular disease manifestations. Treatment should be
individualized and may need to be prolonged.
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